Virupaksha Organics Limited
Virupaksha was established in 2003, with headquarters in Hyderabad, India by G. Chandra Mouliswar Reddy. His vision was to deliver quality products without compromising on the quality of his employees’ life. Through his sheer perseverance, he expanded Virupaksha from a single manufacturing unit to four units with over 900 employees. Today we take pride in stating that we have a large customer base of over 300 customers with a presence in over 100 countries.
- Phone Number +91 40 23075816
- Website Visit Website
- Products
- APIs
Fexofenadine HCl
Fluconazole
Tramadol
Escitalopram Oxalate
Citalopram Hbr
Crisaborole
Efinaconazole
Bilastine
Tavaborole
Salbutamol Sulphate
Tapentadol
Bempedoic Acid
Tefamidis Meglumine
Isavuconazole
Isavuconazonium Sulfate
Rupatidine
Loratidine
Desloratidine
Linagliptin
Dapagiflozin Propendiol Monohydrate
Siponimod
Dextromethorphan Polistirex
Dapagliflozin - Intermediates
2,4‐Diamino‐6‐(hydroxymethyl)pteridine.HCl
4‐(Methoxycarbonyl)‐alpha‐2‐propynyl‐benzeneacetic acid methyl ester
2‐(5‐Bromo‐2‐methyl benzyl)‐5‐(4‐fluorophenyl)thiophene
5‐Bromo‐2‐chloro‐4‐ethoxydiphenylmethane
2‐(Chloromethyl)‐4‐methylquinazoline
8‐Bromo‐7‐(but‐2‐yn‐1‐yl)‐3‐methyl‐3,7‐dihydro‐1 H ‐purine‐2,6‐dione
(R )‐3‐(Boc‐Amino)piperidine
(3S)‐3‐[4‐[(5‐Bromo‐2‐chlorophenyl)methyl]phenoxy]tetrahydro‐furan
3‐(1‐Piperazinyl)‐1,2‐benzisothiazole
(1R ,2R )‐1,2‐Cyclohexanedimethanol
(3aR ,4S ,7R ,7aS ) 4,7‐Methano‐1H ‐isoindole‐1,3(2H )‐dione
(R,R)‐1,2‐Bis(methanesulfonyloxymethyl)cyclohexane
3‐(4‐Chlorobutyl)‐1H ‐indole‐5‐carbonitrile
5‐Aminobenzofuran‐2‐carboxylic acid ethyl ester
Ethyl5‐(4‐tert‐butoxy‐carbonyl‐1‐piperizinyl)benzofuran‐2‐carboxilate
N‐[3‐(Trifluoromethyl)phenyl]piperazine hydrochloride
(2‐cyanophenyl)acetic acid
2‐Pyridylacetic Acid Hydrochloride
(2R,3S)‐2‐(2,4‐Difluorophenyl)‐3‐methyl‐[(1H‐1,2,4‐triazol‐1‐yl)methyl]oxirane
7‐chloro‐1H‐quinazolin‐4‐one
1‐[[(2R, 3S)‐2‐(2, 4‐Difluorophenyl)‐3‐methyloxiranyl] methyl]‐1H‐1, 2, 4‐
4‐methylene piperidine‐HCl
1‐(((2R,3S)‐2‐(2,5‐difluorophenyl)‐3‐Methyloxiran‐2‐yl)Methyl)‐1H‐1,2,4‐ triazole
(2R,3R)‐3‐(2, 5‐Difluorophenyl)‐3‐hydroxy‐2‐Methyl‐4‐(1H‐1,2,4‐triazol‐1‐ yl)thiobutyramide Hydrate Hydrosulfate
(S )‐2‐chloro‐1‐(2,4‐dichlorophenyl)ethyl methanesulfonate
1‐[[(2R ,3S )‐2‐(2, 4‐Difluorophenyl)‐3‐methyloxiranyl] methyl]‐1 H ‐1, 2, 4‐ triazole
(2R,3R)‐3‐(2,4‐Difluorophenyl)‐3‐hydroxy‐2‐Methyl‐4‐(1H‐1,2,4‐triazol‐1‐ yl)thiobutyramide
2‐Bromo‐5‐fluorobenzyl alcohol
2‐Bromo‐5‐methoxybenzyl alcohol
(±)‐2,6‐Diamino‐4,5,6,7‐tetrahydro benzothiazole
(R)‐3‐Amino‐1‐butanol
3α‐Hydroxy‐7‐oxo‐5β‐cholanic Acid
(3alpha,5beta,6alpha)‐6‐Ethyl‐3‐hydroxy‐7‐oxocholan‐24‐oic acid - Contact Details
- Contact Person
Mr. M.Bala Subba Reddy